About : IP/Patents

Our Extensive Intellectual Property Profile

Verenium owns a robust intellectual property portfolio with patents covering our key technologies in the discovery, optimization, production and use of novel protein-based products. In addition, we maintain numerous composition of matter patents covering our novel enzyme products and product candidates. Verenium currently has over 300 issued patents and over 400 patents pending (as of June 2008).

Selected Patents

5,939,250

Production of enzymes having desired activities by mutagenesis.

5,958,672

Protein activity screening of clones having DNA from uncultivated microorganisms

6,001,574

Production and use of normalized DNA libraries

6,168,919

Screening methods for enzymes and enzyme kits

6,171,820

Saturation mutagenesis in directed evolution

6,280,926

Gene expression library produced from DNA from uncultivated microorganisms and methods for making the same

6,344,328

Method for screening for enzyme activity

6,455,254

Sequence based screening

6,537,776

Synthetic ligation reassembly in directed evolution

6,632,600

Altered thermostability of enzymes